KR20120087652A - Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same - Google Patents
Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same Download PDFInfo
- Publication number
- KR20120087652A KR20120087652A KR1020110008991A KR20110008991A KR20120087652A KR 20120087652 A KR20120087652 A KR 20120087652A KR 1020110008991 A KR1020110008991 A KR 1020110008991A KR 20110008991 A KR20110008991 A KR 20110008991A KR 20120087652 A KR20120087652 A KR 20120087652A
- Authority
- KR
- South Korea
- Prior art keywords
- ginger
- extract
- ginger extract
- supercritical
- extraction
- Prior art date
Links
- 235000020708 ginger extract Nutrition 0.000 title claims abstract description 67
- 229940002508 ginger extract Drugs 0.000 title claims abstract description 64
- 238000004519 manufacturing process Methods 0.000 title claims description 36
- 241000234314 Zingiber Species 0.000 claims abstract description 84
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 84
- 235000008397 ginger Nutrition 0.000 claims abstract description 84
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 26
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 claims abstract description 21
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 19
- 235000002780 gingerol Nutrition 0.000 claims abstract description 17
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000010649 ginger oil Substances 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 72
- 238000000605 extraction Methods 0.000 claims description 25
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 18
- 230000002401 inhibitory effect Effects 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 2
- 235000015096 spirit Nutrition 0.000 claims 1
- 239000000284 extract Substances 0.000 abstract description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 10
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 description 17
- 230000003013 cytotoxicity Effects 0.000 description 16
- 231100000135 cytotoxicity Toxicity 0.000 description 16
- 238000002835 absorbance Methods 0.000 description 15
- 230000002000 scavenging effect Effects 0.000 description 12
- 239000011888 foil Substances 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 230000002292 Radical scavenging effect Effects 0.000 description 9
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 5
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000000638 solvent extraction Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 241000219122 Cucurbita Species 0.000 description 3
- 235000009852 Cucurbita pepo Nutrition 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- AIULWNKTYPZYAN-SFHVURJKSA-N (10)-Gingerol Chemical compound CCCCCCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 AIULWNKTYPZYAN-SFHVURJKSA-N 0.000 description 2
- BCIWKKMTBRYQJU-INIZCTEOSA-N (8)-Gingerol Chemical compound CCCCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 BCIWKKMTBRYQJU-INIZCTEOSA-N 0.000 description 2
- ZEASWHWETFMWCV-UHFFFAOYSA-N 7-O-(2-O-Acetyl-6-O-Methyl-beta-D-glucuronoside)-4',5,7-Trihydroxyflavone Natural products C=1C(O)=C(O)C2=C(O)C(=O)C=C(C3C(CC4=C(O)C=C(O)C=C4O3)OC(=O)C=3C=C(O)C(O)=C(O)C=3)C=C2C=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 ZEASWHWETFMWCV-UHFFFAOYSA-N 0.000 description 2
- VSDUZFOSJDMAFZ-UHFFFAOYSA-N 8-gingerol Natural products COC(=O)C(N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-UHFFFAOYSA-N 0.000 description 2
- AIULWNKTYPZYAN-UHFFFAOYSA-N 810gingerol Natural products CCCCCCCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 AIULWNKTYPZYAN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000010907 Cyclooxygenase 2 Human genes 0.000 description 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 108010067755 dinitrophenyl-bovine serum albumin Proteins 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 229940102465 ginger root Drugs 0.000 description 1
- 235000012432 gingerbread Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Seasonings (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
Description
본 발명은 초임계 추출방법을 이용하여 항염 효과가 높은 생강 추출물을 제조하는 방법 및 이에 따른 생강 추출물에 대한 것이다.
The present invention relates to a method for producing a ginger extract with high anti-inflammatory effect by using a supercritical extraction method and to a ginger extract accordingly.
생강은 우리나라뿐 아니라 세계적으로 널리 이용되고 있는 향신료의 하나이며 식품의 관능성을 향상시키기 위해 첨가하는 조미성분의 하나로 널리 이용되고 있다. 또한, 생강은 인체에 유익한 여러 가지 성분이 함유되어 있어 차(tea)나 약재로 널리 쓰여 왔다. Ginger is one of spices widely used not only in Korea but also in the world and is widely used as one of the seasoning ingredients added to improve the sensory properties of food. In addition, ginger contains a variety of ingredients beneficial to the human body has been widely used as tea (tea) or medicine.
생강은 생강과에 속하는 아열대 및 열대성 다년생 식물로서 근경을 주로 이용하여, 특유의 향과 매운 맛이 있어서 오랫동안 향신료로 사용되어 왔다. 한방에서는 생강의 뿌리줄기 말린 것을 건강이라는 약재로 쓰고 있다. 건강은 소화불량 구토설사에 효과가 있고, 혈액순환을 촉진하며 항염증과 진통효과가 있다.Ginger is a subtropical and tropical perennial plant belonging to the family Ginger, and has been used as a spice for a long time due to its characteristic aroma and spicy taste. In oriental medicine, ginger root stems are used as a health medicine. Health is effective in indigestion and vomiting diarrhea, promotes blood circulation, anti-inflammatory and analgesic effect.
생강의 4분의 3정도는 수분이며 전체 고형분의 40~60%는 전분이 차지하고 있다. 정유성분으로는 진기베롤(zingiberol), 진기베렌(zingiberene) 등이 함유되어 있으며, 특이 성분으로는 6-진저롤(gingerol, 0.1~0.3%), 8-진저롤(gingerol), 10-진저롤(gingerol), 진저론(zingerone), 6-쇼가올(6-shogaol, 0.04%), 감마-아미노부티르산(gamma-aminobutyric acid) 등이 있다.
About three quarters of ginger is water, and about 40-60% of the total solids are made up of starch. Essential oils include zingiberol and zingiberene, and specific ingredients include 6-gingerol (0.1-0.3%), 8-gingerol and 10-gingerol. , Zingerone, 6-shogaol (0.04%), gamma-aminobutyric acid, and the like.
초임계 유체에 의한 천연물의 추출은 많은 관심의 대상이 되고 있다. 초임계 유체를 이용하는 추출 및 분리기술은 임계점 부근 또는 임계점을 초월하는 영역에서 초임계 유체의 특이한 물리적 특성을 이용하여 혼합성분 중 특정성분을 선택적으로 추출하는 분리기술의 하나이다.Extraction of natural products by supercritical fluids has been of great interest. Extraction and separation techniques using supercritical fluids are one of the separation techniques for selectively extracting specific components from the mixed components using specific physical properties of the supercritical fluid in or near the critical point.
혼합물에서 특정성분을 분리하는 방법에는 구성성분의 휘발도 차이를 이용하는 증류법과 특정 용매에 대한 용해도 차이를 이용하는 용매추출법 등이 있다. 증류법은 높은 비점에서 조작됨으로 천연물의 증류에서는 고온에 의한 유효성분의 분해와 파괴 등이 문제가 된다. 용매추출법은 적절한 유기용제의 선정, 추출상에 유기용제의 잔존 및 제거공정의 필요, 낮은 분리효과 등의 어려움이 수반된다. 그러나 초임계 유체 추출법은 증류법에 비하여 임계온도 부근의 저온에서 조작이 가능하므로 저에너지 소비공정이며 천연물과 같이 열에 민감한 물질에 적용하기 좋다. 또 용매추출법과 비교하여 볼 때 초임계 유체는 확산계수가 크고 점도가 낮아 추출속도가 빠르며 상분리가 용이하여 용매추출법처럼 잔존용매의 제거공정이 필요 없다.
Methods for separating specific components from the mixture include distillation using the difference in volatility of the components and solvent extraction using the difference in solubility in a specific solvent. Distillation is operated at a high boiling point, so in the distillation of natural products, decomposition and destruction of the active ingredient due to high temperature becomes a problem. Solvent extraction involves difficulties in selecting an appropriate organic solvent, remaining organic solvent in the extraction phase, the need for a removal process, and low separation effect. However, the supercritical fluid extraction method is a low energy consumption process because it can be operated at a low temperature near the critical temperature compared to the distillation method and is suitable for heat sensitive materials such as natural products. Compared with the solvent extraction method, the supercritical fluid has a high diffusion coefficient and low viscosity, so the extraction speed is fast, and phase separation is easy. Therefore, the residual solvent removal process is not required like the solvent extraction method.
생강은 여러 기능성 중에서도 높은 항염 활성을 나타내지만 이를 활용한 다양한 기능성 식품이나 염증 치료용 약학 조성물을 개발하고자 할 때 기호적으로 양호하지 않은 맛과 특유의 향기 특성을 나타내기 때문에 제약이 따른다. Ginger shows high anti-inflammatory activity among various functionalities, but when it is developed various functional foods or pharmaceutical compositions for treating inflammation, it has a taste that is not satisfactorily good and peculiar aroma characteristic is followed.
따라서 생강 특유의 맛과 향기를 제거하거나 보완할 수 있을 뿐 아니라 짧은 시간 안에 추출 수율을 높으면서도 항염 활성성분 중 하나인 진저롤(gingerol)의 함량이 높은 추출물을 얻는 추출방법의 개발이 필요한 실정이다. 또한, 생강 추출물 뿐 아니라 생강을 초임계 추출하고 남은 생강박의 활용방법에 대한 개발이 필요하다.
Therefore, it is necessary to develop an extraction method that can not only remove or supplement the unique flavor and aroma of ginger but also increase the extraction yield in a short time, but also obtain an extract with a high content of gingerol, one of the anti-inflammatory active ingredients. In addition, it is necessary to develop not only ginger extract but also how to use ginger foil after supercritical extraction of ginger.
본 발명은 생강 분말을 초임계 이산화탄소를 이용하여 35 ~ 55℃의 온도, 100~ 400 bar의 압력에서 1 ~ 3 mL/min의 유속으로 1 ~ 3 시간 동안 초임계 추출하여 생강유를 얻는 것을 특징으로 하는 생강 추출물 제조방법을 제공한다.
The present invention is characterized by obtaining ginger oil by supercritical extraction of ginger powder for 1 to 3 hours at a flow rate of 1 to 3 mL / min at a temperature of 35 to 55 ° C. and a pressure of 100 to 400 bar using supercritical carbon dioxide. It provides a method for producing ginger extract.
본 발명은 또한, 상기 생강유를 얻은 후 남은 박을 생강 박 무게에 대하여 5 ~ 15배(w/v)의 60 ~ 90% 주정을 가하고 실온에서 6 ~ 36시간 동안 정치하는 것을 특징으로 하는 생강 추출물 제조방법을 제공한다.
The present invention is also characterized in that the ginger remaining after obtaining the ginger oil is added to 60 ~ 90% alcohol of 5 to 15 times (w / v) with respect to the weight of ginger foil and left for 6 to 36 hours at room temperature It provides a method for producing an extract.
본 발명은 생강 특유의 맛과 향기를 제거하거나 보완할 수 있을 뿐 아니라 짧은 시간 안에 추출 수율이 높으면서도 진저롤(gingerol)의 함량이 높은 추출물을 얻을 수 있는 생강 추출물 제조방법을 제공한다. The present invention provides a ginger extract manufacturing method that can not only remove or supplement the unique flavor and aroma of ginger but also obtain a high extracting yield in a short time, but also a high content of gingerol (gingerol).
본 발명은 생강을 초임계 추출하고 남은 생강박을 활용하여 항염 활성이 높은 생강 추출물을 제공한다.
The present invention provides a ginger extract with high anti-inflammatory activity by utilizing the remaining ginger foil after supercritical extraction of ginger.
이에 본 발명은 바람직한 제1구현예로서 (S1) 생강 분말을 준비하는 단계; 및 (S2) 생강 분말을 초임계 이산화탄소를 이용하여 35 ~ 55℃의 온도, 100~ 400 bar의 압력에서 1 ~ 3 mL/min의 유속으로 1 ~ 3 시간 동안 초임계 추출법으로 추출하여 생강유를 얻는 단계;를 포함하는 생강 추출물 제조방법을 제공한다.
Accordingly, the present invention provides a step of preparing a ginger powder (S1) as a first embodiment; And (S2) ginger powder is extracted by supercritical extraction for 1 to 3 hours at a flow rate of 1 to 3 mL / min at a temperature of 35 to 55 ° C. and a pressure of 100 to 400 bar using supercritical carbon dioxide. It provides a method for producing ginger extract comprising;
상기 구현예에 의한 생강 초임계 추출물 제조방법에서, (S1) 단계에서의 생강 분말은 평균 입도가 50 ~ 500 μm인 생강 추출물 제조방법을 제공한다.
In the ginger supercritical extract manufacturing method according to the embodiment, the ginger powder in the step (S1) provides a ginger extract manufacturing method having an average particle size of 50 ~ 500 μm.
상기 구현예에 의한 생강 초임계 추출물 제조방법에서, 추출 수율이 2.5 ~ 3.0중량%인 생강 추출물 제조방법을 제공한다.
In the ginger supercritical extract manufacturing method according to the embodiment, the extraction yield provides a ginger extract manufacturing method of 2.5 to 3.0% by weight.
상기 구현예에 의한 생강 초임계 추출물 제조방법에서, (S2) 단계 이후에 (S3) 생강유를 얻은 후 남은 박을 생강 박 무게에 대하여 5 ~ 15배(w/v)의 60 ~ 90% 주정을 가하고 실온에서 6 ~ 36시간 동안 정치하는 단계; 및 (S4) 여과 및 농축하는 단계;를 더 포함하는 생강 추출물 제조방법을 제공한다.
In the ginger supercritical extract manufacturing method according to the above embodiment, after the step (S2) (S3) after the ginger oil obtained from the remaining 5 to 15 times (w / v) of 60 ~ 90% alcohol by the weight of ginger foil Adding and standing at room temperature for 6 to 36 hours; And (S4) filtration and concentration; provides a ginger extract manufacturing method further comprising.
본 발명은 바람직한 제2구현예로서 상기의 제조방법에 따라 제조된 생강 추출물을 제공한다.
The present invention provides a ginger extract prepared according to the above production method as a second preferred embodiment.
상기 제2구현예에 의한 생강 초임계 추출물에서, 진저롤(gingerol)의 함량이 21 ~ 25중량%인 생강 추출물을 제공한다.
In the ginger supercritical extract according to the second embodiment, a ginger extract having a content of gingerol (gingerol) is 21 to 25% by weight.
상기 제2구현예에 의한 생강 추출물에서, 10 ~ 100㎍/mL의 농도에서 NO(Nitric Oxide) 생성 억제 효과가 50 ~ 98%인 생강 추출물을 제공한다.
In the ginger extract according to the second embodiment, it provides a
본 발명은 바람직한 제3구현예로서 상기 생강 추출물을 포함하는 항염증 조성물을 제공한다.
The present invention provides an anti-inflammatory composition comprising the ginger extract as a third embodiment.
도 1은 본 발명의 바람직한 일 실시예에 따라 생강의 초임계 추출 온도와 압력별 수율 변화를 나타내는 그래프이다.
도 2는 본 발명의 바람직한 일 실시예에 따라 35℃의 온도에서 압력을 달리하여 추출한 생강 추출물의 외관을 나타내는 사진이다.
도 3은 본 발명의 바람직한 일 실시예에 따라 초임계 추출 온도와 압력을 달리하여 추출한 생강 추출물의 항산화 활성을 비교하여 나타낸 그래프이다. 이때, 도 3a는 35℃에서 초임계 추출한 생강 추출물의 항산화 활성을 나타낸 것이고, 도 3b는 45℃, 도 3c는 55℃에서 초임계 추출한 생강 추출물의 항산화 활성을 나타낸 그래프이다.
도 4는 본 발명의 바람직한 일 실시예에 따른 생강 초임계 추출물의 세포독성 및 NO 소거능을 나타내는 그래프이다. 구체적으로, 도 4a는 생강 초임계 추출물의 세포독성을 나타내는 그래프이고, 도 4b는 생강 초임계 추출물의 NO 소거능을 나타내는 그래프이다.
도 5는 본 발명의 바람직한 일 실시예에 따른 생강 초임계 박추출물의 세포독성 및 NO 소거능을 나타내는 그래프이다. 구체적으로, 도 5a는 생강 초임계 박추출물의 세포독성을 나타내는 그래프이고, 도 5b는 생강 초임계 박 추출물의 NO 소거능을 나타내는 그래프이다.
도 6은 본 발명의 바람직한 비교예에 따른 생강 에탄올 추출물의 세포독성 및 NO 소거능을 나타내는 그래프이다. 구체적으로, 도 6a는 생강 에탄올 추출물의 세포독성을 나타내는 그래프이고, 도 6b는 생강 에탄올 추출물의 NO 소거능을 나타내는 그래프이다.
도 7은 진저롤(gingerol)의 세포독성 및 NO 소거능을 나타내는 그래프이다. 구체적으로, 도 7a는 진저롤의 세포독성을 나타내는 그래프이고, 도 7b는 진저롤의 NO 소거능을 나타내는 그래프이다.1 is a graph showing a change in yield of each supercritical extraction temperature and pressure of ginger according to an embodiment of the present invention.
Figure 2 is a photograph showing the appearance of the ginger extract extracted by varying the pressure at a temperature of 35 ℃ according to an embodiment of the present invention.
Figure 3 is a graph showing the antioxidant activity of the ginger extract extracted by varying the supercritical extraction temperature and pressure according to an embodiment of the present invention. At this time, Figure 3a shows the antioxidant activity of the supercritical extract ginger extract at 35 ℃, Figure 3b is 45 ℃, Figure 3c is a graph showing the antioxidant activity of the supercritical extract ginger extract at 55 ℃.
Figure 4 is a graph showing the cytotoxicity and NO scavenging ability of the ginger supercritical extract according to an embodiment of the present invention. Specifically, Figure 4a is a graph showing the cytotoxicity of the ginger supercritical extract, Figure 4b is a graph showing the NO scavenging ability of the ginger supercritical extract.
Figure 5 is a graph showing the cytotoxicity and NO scavenging ability of ginger supercritical extract according to an embodiment of the present invention. Specifically, Figure 5a is a graph showing the cytotoxicity of ginger supercritical gourd extract, Figure 5b is a graph showing the NO scavenging ability of the ginger supercritical gourd extract.
6 is a graph showing the cytotoxicity and NO scavenging ability of ginger ethanol extract according to a preferred comparative example of the present invention. Specifically, Figure 6a is a graph showing the cytotoxicity of ginger ethanol extract, Figure 6b is a graph showing the NO scavenging ability of the ginger ethanol extract.
7 is a graph showing the cytotoxicity and NO scavenging ability of gingerol. Specifically, Figure 7a is a graph showing the cytotoxicity of the ginger roll, Figure 7b is a graph showing the NO scavenging ability of the ginger roll.
이하, 본 발명을 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명은 초임계 추출방법을 이용하여 항염 효과가 높은 생강 추출물을 제조하는 방법 및 이에 따른 생강 추출물을 제공하는 것으로, 특히 생강 분말을 초임계 이산화탄소를 이용하여 35 ~ 55℃의 온도, 100~ 400 bar의 압력에서 1 ~ 3 mL/min의 유속으로 1 ~ 3 시간 동안 초임계 추출함으로써, 생강 특유의 맛과 향기를 제거하거나 보완할 수 있을 뿐 아니라 짧은 시간 안에 추출 수율이 높으면서도 진저롤(gingerol)의 함량이 높은 추출물을 얻는 방법을 제공한다. 상기 각각의 조건들이 범위를 벗어날 경우, 추출 수율이 낮아지거나 추출 수율이 더 이상 증가하지 않아 경제적으로 바람직하지 못하다.
The present invention provides a method for producing a ginger extract having a high anti-inflammatory effect by using a supercritical extraction method and a ginger extract accordingly, in particular ginger powder using a supercritical carbon dioxide temperature of 35 ~ 55 ℃, 100 ~ 400 Supercritical extraction for 1 to 3 hours at a flow rate of 1 to 3 mL / min at bar pressure not only eliminates or complements the ginger's distinctive taste and aroma, but also gives a high extraction yield in a short time, while gingering It provides a method of obtaining an extract having a high content of. If the respective conditions are out of range, the extraction yield is lowered or the extraction yield is no longer increased, which is economically undesirable.
또한, 본 발명은 상기 초임계 추출 후 남은 생강 박을 박 무게에 대하여 5 ~ 15배(w/v)의 60 ~ 90% 주정을 가하고 실온에서 6 ~ 36시간 동안 정치시킴으로써, 생강박을 활용하여 항염 활성이 높은 생강 추출물을 얻는 방법을 제공한다.
In addition, the present invention is added to 60 ~ 90% alcohol of 5 to 15 times (w / v) with respect to the weight of the ginger foil remaining after the supercritical extraction and allowed to stand for 6 to 36 hours at room temperature, by using a ginger foil Provided is a method for obtaining ginger extract with high anti-inflammatory activity.
이를 위하여 본 발명은 (S1) 생강 분말을 준비하는 단계; 및 (S2) 생강 분말을 초임계 이산화탄소를 이용하여 35 ~ 55℃의 온도, 100 ~ 400 bar의 압력에서 1 ~ 3 mL/min의 유속으로 1 ~ 3 시간 동안 초임계 추출법으로 추출하여 생강유를 얻는 단계;를 포함하는 생강 추출물 제조방법을 제공한다.
To this end, the present invention comprises the steps of preparing a ginger powder (S1); And (S2) ginger powder is extracted by supercritical extraction for 1 to 3 hours at a flow rate of 1 to 3 mL / min at a temperature of 35 to 55 ° C. and a pressure of 100 to 400 bar using supercritical carbon dioxide. It provides a method for producing ginger extract comprising;
먼저, (S1) 단계에서는 생강 분말을 준비한다. 생강 분말은 평균 입도가 50 ~ 500 μm인 것이 추출속도가 높으므로 바람직하다.
First, the ginger powder is prepared in step (S1). Ginger powder has an
(S2) 단계에서는 상기 생강 분말을 초임계 이산화탄소를 이용하여 35 ~ 55℃의 온도, 100 ~ 400 bar의 압력에서 1 ~ 3 mL/min의 유속으로 1 ~ 3 시간 동안 초임계 추출법으로 추출한다.In step (S2), the ginger powder is extracted by supercritical extraction for 1 to 3 hours at a flow rate of 1 to 3 mL / min at a temperature of 35 to 55 ° C. and a pressure of 100 to 400 bar using supercritical carbon dioxide.
상기 추출방법에 의하면 생강유(생강 초임계 추출물)를 짧은 시간 안에 2.5 ~ 3.0중량%의 수율로 얻을 수 있다.According to the extraction method ginger oil (ginger supercritical extract) can be obtained in a yield of 2.5 to 3.0% by weight in a short time.
그리고, 상기 추출방법에 의하면 항염 활성성분 중 하나인 진저롤(gingerol)의 함량이 21 ~ 25중량%인 생강 추출물을 얻을 수 있다. 즉, 상기 조건으로 생강 분말을 초임계 추출하는 경우 생강 특유의 맛과 향기를 제거하거나 보완할 수 있을 뿐 아니라 짧은 시간 안에 추출 수율을 높으면서도 진저롤(gingerol)의 함량이 높은 추출물(생강유)을 얻을 수 있다.
In addition, according to the extraction method, the ginger extract having a content of 21 to 25% by weight of gingerol, which is one of the anti-inflammatory active ingredients, can be obtained. That is, when the supercritical extraction of ginger powder under the above conditions, it is possible not only to remove or supplement the flavor and flavor peculiar to ginger, but also to extract extracts (ginger oil) having a high content of gingerol in a short time. You can get it.
또한, 본 발명의 생강 추출물 제조방법은 상기 (S2) 단계 이후에, (S3) 생강유를 얻은 후 남은 박을 생강 박 무게에 대하여 5 ~ 15배(w/v)의 60 ~ 90% 주정을 가하고 실온에서 6 ~ 36시간 동안 정치하는 단계; 및 (S4) 여과 및 농축하는 단계;를 더 포함할 수 있다. In addition, the ginger extract manufacturing method of the present invention after the (S2) step, (S3) 60 ~ 90% alcohol of 5 to 15 times (w / v) with respect to the weight of the ginger foil remaining after obtaining ginger oil Adding and standing at room temperature for 6 to 36 hours; And (S4) filtering and concentrating.
그리고, 상기 방법에 의하면 생강을 초임계 추출하고 생강박을 활용하여 10 ~ 100㎍/mL의 농도에서 NO(Nitric Oxide) 생성 억제 효과가 50 ~ 98%인 생강 추출물을 얻을 수 있다. 즉, 상기 추출방법에 의하면 생강을 초임계 추출하고 남은 생강박을 활용하여 항염 활성이 높은 생강 추출물을 얻을 수 있다.
In addition, according to the above method, a ginger extract having a supercritical extraction of ginger and 50 to 98% of NO (Nitric Oxide) production inhibitory effect at a concentration of 10 to 100 µg / mL can be obtained by using ginger foil. That is, according to the extraction method, the ginger extract having high anti-inflammatory activity can be obtained by using the remaining ginger foil after the supercritical extraction of ginger.
염증반응이 일어나면 여러 가지 염증인자들(proinflammatory mediators)이 만들어지는데, 염증인자에는 inducible nitric oxide synthase(iNOS)에 의해서 만들어지는 NO(Nitric Oxide)와 cyclooxygenase-2 (COX-2)에 의해서 만들어지는 prostaglandin E2(PGE2) 등이 있다. 이러한 염증 인자는 염증반응의 전사인자인 nuclear factor-kB(NF-kB)를 활성화시키며, 그 결과 과량의 NO와 PGE2를 생성하여 염증을 일으킨다. 따라서, NO(Nitric Oxide)의 생성을 억제하면 염증 반응을 억제할 수 있게 된다.
When the inflammatory reaction occurs, several proinflammatory mediators are produced, which are prostaglandin produced by nitric oxide (NO) and cyclooxygenase-2 (COX-2), which are produced by inducible nitric oxide synthase (iNOS). E 2 (PGE 2 ), and the like. These inflammatory factors activate nuclear factor-kB (NF-kB), a transcription factor of the inflammatory response, resulting in the production of excess NO and PGE 2 to cause inflammation. Therefore, by inhibiting the production of nitric oxide (NO) it is possible to suppress the inflammatory response.
다음으로, 본 발명은 상기한 생강 추출물 제조방법에 따른 생강 추출물을 포함하는 항염증 조성물을 제공한다. Next, the present invention provides an anti-inflammatory composition comprising a ginger extract according to the ginger extract manufacturing method.
상기 항염증 조성물은 항염 기능성을 가진 화장료 조성물, 약학 조성물, 식품 조성물 등 다양한 산업 분야에 활용될 수 있어 매우 유용한 발명이다.
The anti-inflammatory composition is a very useful invention because it can be used in various industrial fields, such as cosmetic compositions, pharmaceutical compositions, food compositions with anti-inflammatory functionality.
이하, 본 발명의 구성을 실시예를 통하여 보다 상세히 설명하나, 본 발명의 범위가 하기 실시예로 한정되는 것은 아니다.
Hereinafter, the configuration of the present invention in more detail through examples, but the scope of the present invention is not limited to the following examples.
[[
실시예Example
]]
실시예Example 1 One
초임계유체추출장치(SFT-100XW, Supercritical Fluid Technologies, Inc., Newark, DE, USA)를 사용하였고, 평균입도가 50 ~ 500 μm인 생강 분말 18g을 100 mL의 용량의 추출조에 넣어 추출하였다. 시료의 추출조건은 35, 45, 55℃온도에서 100, 200, 300, 400 bar로 압력을 변화시키며 실시하였고, 이산화탄소의 유속은 2 mL/min로 다이나믹 모드에서 2시간동안 추출하여 추출물을 곧바로 용기(vial)에 받아내었다.
A supercritical fluid extractor (SFT-100XW, Supercritical Fluid Technologies, Inc., Newark, DE, USA) was used, and 18 g of ginger powder having an average particle size of 50 to 500 μm was extracted into a 100 mL extraction tank. The extraction conditions of the samples were carried out with varying pressure at 35, 45, 55 ℃ temperature to 100, 200, 300, 400 bar, the flow rate of carbon dioxide is 2 mL / min for 2 hours in the dynamic mode to extract the container immediately I received it in (vial).
실시예Example 2 2
실시예 1에서 생강 초임계 추출물(생강유)을 얻고 남은 부산물인 생강박의 무게에 대하여 10배(w/v)의 70% 주정을 가하고 실온에서 24시간 동안 정치하여 생강(박) 추출물을 얻었다.
In Example 1, a ginger supercritical extract (ginger oil) was obtained, and 10 times (w / v) of 70% alcohol was added to the weight of the remaining by-product ginger foil, and allowed to stand at room temperature for 24 hours to obtain a ginger (bak) extract. .
비교예Comparative example
평균입도가 50 ~ 500 μm인 생강 분말에 상기 생강 분말 무게에 대하여 10배(w/v)의 70% 주정(에탄올)을 가하고 실온에서 24시간 동안 정치하여 생강 추출물을 얻었다.
10 times (w / v) of 70% spirit (ethanol) was added to the ginger powder having an average particle size of 50 to 500 μm, and left at room temperature for 24 hours to obtain a ginger extract.
[[
실험예Experimental Example
]]
실험예Experimental Example 1: 생강의 1: ginger 초임계Supercritical 추출 수율 Extraction yield
생강의 초임계 추출 수율은 도 1에 나타낸 바와 같이 동일한 온도에서는 압력이 증가할수록 증가하는 것으로 나타났으며, 100 bar에서는 온도가 35℃에서 55℃로 증가할수록 수율이 1.91%에서 1.07%로 감소한 반면 200~400 bar에서는 온도가 증가할수록 추출수율이 증가하여 55℃의 경우 각각 2.41, 2.92, 3.00%를 나타내었다.
The supercritical extraction yield of ginger increased with increasing pressure at the same temperature as shown in FIG. 1, while the yield decreased from 1.91% to 1.07% at 100 bar as the temperature increased from 35 ° C to 55 ° C. At 200-400 bar, the extraction yield increased with increasing temperature, showing 2.41, 2.92 and 3.00% at 55 ℃, respectively.
실험예Experimental Example 2: 생강 추출물의 색도 및 외관 2: Color and Appearance of Ginger Extract
색도는 color and color difference meter(Color QUESTⅡ, Hunter Lab, USA)를 이용하여 L(lightness), a(redness/greenness), b(yellowness/blueness)값을 측정하였으며, 이때 표준 백색판은 L=92.68, a=-0.81, b=0.86의 값을 가진 것을 사용하였다.The chromaticity was measured by using a color and color difference meter (Color QUESTⅡ, Hunter Lab, USA) to measure L (lightness), a (redness / greenness), and b (yellowness / blueness), with standard white plate L = 92.68 , a = -0.81 and b = 0.86 were used.
도 2는 35℃에서 압력을 달리하여 추출한 생강 추출물의 외관을 나타낸 것으로, 100 bar에서는 노란색을 나타내었고 압력이 증가할수록 생강 고유의 색소성분이 많이 추출되어 색이 진하여지면서 400 bar에서는 붉은 계통의 적갈색을 나타내었다. 또한, 초임계 추출조건에 따른 생강 추출물의 색도 측정 결과 하기 표 1에서 나타낸 바와 같이 모든 온도조건에서 압력이 증가함에 따라 L 값과 b 값이 크게 감소하였으며 특히 b 값의 감소가 큰 것으로 나타나 생강의 색소 추출과 b 값의 관련성이 가장 큰 것을 알 수 있었다.
Figure 2 shows the appearance of the ginger extract extracted by varying the pressure at 35 ℃, it was yellow at 100 bar and as the pressure is increased a lot of ginger's own pigment components are extracted and the color becomes darker at 400 bar of the red system It is reddish brown. In addition, as a result of measuring the chromaticity of the ginger extract according to the supercritical extraction condition, as shown in Table 1, the L value and the b value decreased significantly with increasing pressure at all temperature conditions. It was found that the correlation between the pigment extraction and the b value was the largest.
실험예Experimental Example 3: 생강 추출물의 3: of ginger extract 진저롤Gingerbread (( gingerolgingerol ) 함량) content
생강 초임계 추출물에 함유된 6-진저롤(6-gingerol), 8-진저롤(8-gingerol), 10-진저롤(10-gingerol), 6-쇼가올(6-shogaol) 등의 진저롤(gingerol)의 함량을 HPLC(Jasco Co., Japan)를 이용하여 정량하였다. 컬럼은 Waters symmetry C-8 reversed phase column (150 × 3.9 mm, Cat. No. WATO 54235)을 이용하였고, 이동상은 methanol-water(46:35, v/v)를 1 mL/min의 속도로 용출하였으며, 시료의 검출은 UV detecter로 282 nm에서 측정하였다. 분석표준물질인 6-진저롤, 8-진저롤, 10-진저롤, 6-쇼가올은 크로마덱스(Chromadex)사에서 구입하여 사용하였다. 실시예 1의 생강 추출물을 5 mg/mL 농도로 메탄올에 녹인 후 0.45 μm syringe filter(Millipore)로 여과하여 제조하였고 이를 분석용 시료로 사용하였다.
Gingerol, such as 6-gingerol, 8-gingerol, 10-gingerol, 6-shogaol, etc. contained in ginger supercritical extract Was determined using HPLC (Jasco Co., Japan). The column used a Waters symmetry C-8 reversed phase column (150 × 3.9 mm, Cat.No. WATO 54235), and the mobile phase eluted methanol-water (46:35, v / v) at a rate of 1 mL / min. The detection of the sample was measured at 282 nm with a UV detecter. Analytical standards 6- ginger roll, 8- ginger roll, 10- ginger roll, 6- shogaol was purchased from Chromadex. The ginger extract of Example 1 was dissolved in methanol at a concentration of 5 mg / mL and filtered by 0.45 μm syringe filter (Millipore), which was used as a sample for analysis.
초임계 추출 온도와 압력별 생강 추출물의 진저롤 함량 변화를 측정한 결과는 하기 표 2에 나타내었다. 진저롤 함량 분포는 6-진저롤이 가장 높은 함량을 나타내었고(10.78~17.17%) 8-진저롤 (2.38~4.08%), 10-진저롤 (1.01~3.07%), 6-쇼가올 (0.64~1.09%)의 순으로 나타났다. 추출온도와 상관없이 100 bar에서 가장 낮은 진저롤 함량을 나타내었고 추출온도가 증가할수록 각각 20.00, 18.02, 15.13%로 낮아지는 경향이었다. 반면 200~400 bar의 범위에서는 21.46~24.48%로서 큰 차이가 없는 진저롤(gingerol) 함량을 나타내었다.
The results of measuring the ginger roll content change of ginger extract according to supercritical extraction temperature and pressure are shown in Table 2 below. Ginger roll content distribution showed the highest content of 6- ginger roll (10.78 ~ 17.17%), 8- ginger roll (2.38 ~ 4.08%), 10- ginger roll (1.01 ~ 3.07%), 6- shogaol (0.64 ~ 1.09% ). Regardless of the extraction temperature, the lowest ginger roll content was shown at 100 bar, and as the extraction temperature increased, it decreased to 20.00, 18.02 and 15.13%, respectively. On the other hand, in the range of 200-400 bar, 21.46 ~ 24.48% showed no significant difference in gingerol content.
(bar)pressure
(bar)
실험예Experimental Example
4: 생강 추출물의 항산화 활성 4: Antioxidant Activity of Ginger Extract
DPPHDPPH (2,2-(2,2- diphenyl피덴 -1--One- picrylpicryl -- hydrazylhydrazyl ) ) 라디칼Radical 소거능Scatters
추출물의 항산화력은 윌리엄 등의 방법을 변형한 DPPH 라디칼 소거활성으로 측정하였다. 메탄올에 녹인 0.15 mM DPPH 용액 1 mL와 각 농도별로 희석한 시료 0.05 mL를 혼합하고, 20분경과 후에 525 nm에서 흡광도를 측정하였다. DPPH의 라디칼 소거활성은 시료를 첨가하지 않은 대조구와 비교하여 다음 식에 의하여 백분율로 나타내었다.
The antioxidant activity of the extract was measured by DPPH radical scavenging activity modified by the method of William et al. 1 mL of 0.15 mM DPPH solution dissolved in methanol and 0.05 mL of the diluted sample at each concentration were mixed, and after 20 minutes, the absorbance was measured at 525 nm. The radical scavenging activity of DPPH was expressed as a percentage by the following equation compared to the control without the sample.
(B: Absorbance of control / A: Absorbance of sample)
(B: Absorbance of control / A: Absorbance of sample)
또한, 각 추출물의 라디칼 소거활성은 추출물을 첨가하지 않은 대조구의 흡광도를 1/2로 환원시키는데 필요한 추출물의 농도인 IC50 값으로 나타내었다.
In addition, the radical scavenging activity of each extract was expressed as an IC 50 value, which is the concentration of the extract necessary to reduce the absorbance of the control group without the extract to 1/2.
ABTSABTS 라디칼Radical 소거능Scatters
추출물의 ABTS 라디칼 소거능은 Van der Berg 등의 방법을 변형한 방법으로 측정하였다. 실험 12~16시간 전에 제조해 둔 7 mM ABTS 용액은 734 nm에서 0.7±0.02의 흡광도를 나타내도록 5 mM PBS에 희석한 후 ABTS 용액 1 mL와 각 농도별로 희석한 시료 0.02 mL를 혼합하여 10분경과 후에 734 nm에서 흡광도를 측정하였다. ABTS의 라디칼 소거활성은 시료를 첨가하지 않은 대조구와 비교하여 다음 식에 의하여 백분율로 나타내었다.
ABTS radical scavenging ability of the extract was measured by a modification of Van der Berg et al. The 7 mM ABTS solution prepared 12 to 16 hours before the experiment was diluted in 5 mM PBS to have an absorbance of 0.7 ± 0.02 at 734 nm, and then mixed with 1 mL of the ABTS solution and 0.02 mL of the diluted sample at each concentration. Absorbance was measured at and after 734 nm. The radical scavenging activity of ABTS was expressed as a percentage by the following equation compared to the control without the sample.
(B: Absorbance of control / A: Absorbance of sample)
(B: Absorbance of control / A: Absorbance of sample)
또한, 각 추출물의 라디칼 소거활성은 추출물을 첨가하지 않은 대조구의 흡광도를 1/2로 환원시키는데 필요한 추출물의 농도인 IC50 값으로 나타내었다.
In addition, the radical scavenging activity of each extract was expressed as an IC 50 value, which is the concentration of the extract necessary to reduce the absorbance of the control group without the extract to 1/2.
LinoleicLinoleic acidacid 와 β-And β- carotenecarotene 의 of coupledcoupled oxidationoxidation 에 대한 항산화 활성Antioxidant activity against
Linoleic acid 60 mg, β-carotene 10 mg 그리고 Tween 80 200 mg과 chloroform 10 mL를 혼합하여 농축시킨 후 증류수 50 mL에 용해하여 용액으로 사용하였다. 혼합용액 1 mL와 증류수 2 mL, 그리고 생강 추출물(20 mg/mL EtOH) 0.05 mL를 혼합한 후 40℃ water bath에서 24시간 유지하면서 꺼내어 470 nm에서 흡광도를 측정하였다. 제조 직후의 흡광도 값을 100으로 하여 측정된 흡광도 값으로부터 항산화 활성을 산출하였다. 이때 생강 추출물 대신 증류수를 0.05 mL 처리한 것을 대조구로 하였다.
60 mg of linoleic acid, 10 mg of β-carotene, 200 mg of
초임계 추출 온도와 압력별 생강추출물의 DPPH와 ABTS 라디칼 소거 활성을 측정한 결과는 하기 표 3에 나타낸 바와 같다. DPPH, ABTS 라디칼 소거활성 모두 100 bar에서 가장 높은 IC50 값을 그리고 온도가 증가할수록 높은 IC50 값을 나타내었고 특히 55℃, 100 bar에서는 각각 1641.0, 1156.7 μg/mL로 가장 낮은 항산화 활성을 나타내었다. 200~400 bar의 범위에서는 각각 677.3~721.6 μg/mL과 392.5~434.7 μg/mL로 큰 차이가 나지 않는 항산화 활성을 나타내었다. 한편, Linoleic acid와 β-carotene의 coupled oxidation에 대한 항산화 활성을 측정한 결과는 도 3에 나타낸 바와 같다. 생강 추출물을 첨가하지 않은 대조구의 경우 2시간 경과시 71.1%의 항산화 활성을 갖는 것으로 나타나 짧은 시간에 급격히 산화가 일어남을 알 수 있었다. 생강 추출물을 첨가할 경우 처리구에 따라 차이가 있지만 84.4~99.3%의 활성을 나타내어 대조구에 비해 산화가 크게 억제됨을 알 수 있었다. 또한 24시간 경과시에도 대조구가 52.5%의 항산화 활성을 나타내는 반면 생강 추출물 처리시에는 57.3~77.8%의 항산화 활성을 나타내는 것으로 나타났다. DPPH와 ABTS 라디칼 소거 활성과 마찬가지로 추출온도에 상관없이 100 bar에서 가장 낮은 항산화 활성을 나타내고 200~400 bar의 범위에서는 큰 차이가 나지 않는 항산화 활성을 갖는 것으로 나타났다. 이와 같은 항산화 활성 결과는 앞에서 기술한 추출물의 진저롤 함량의 경향과 거의 유사한 경향인 것으로 생강 추출물의 항산화 활성이 진저롤 함량과 매우 큰 상관관계가 있음을 알 수 있었다.
The results of measuring the DPPH and ABTS radical scavenging activity of ginger extracts by supercritical extraction temperature and pressure are shown in Table 3 below. DPPH, exhibited the ABTS radical scavenging activity As both increase with the highest IC 50 value and the temperature at 100 bar exhibited a higher IC 50 values, especially 55 ℃, 100 bar, respectively 1641.0, the lowest antioxidant activity to 1156.7 μg / mL . In the range of 200-400 bar, 677.3-721.6 μg / mL and 392.5-434.7 μg / mL, respectively, showed no significant antioxidant activity. Meanwhile, the results of measuring the antioxidant activity of the coupled oxidation of linoleic acid and β-carotene are shown in FIG. 3. The control group without the ginger extract had an antioxidant activity of 71.1% after 2 hours, indicating that oxidation occurred rapidly in a short time. When the ginger extract was added to the treatment, the difference was 84.4 ~ 99.3%, indicating that the oxidation was significantly inhibited compared to the control. In addition, the control showed 52.5% antioxidant activity even after 24 hours, whereas ginger extract showed 57.3 ~ 77.8% antioxidant activity. Like DPPH and ABTS radical scavenging activity, it showed the lowest antioxidant activity at 100 bar irrespective of extraction temperature and did not show much difference in the range of 200 ~ 400 bar. The antioxidant activity results showed a tendency almost similar to the tendency of the ginger roll content of the extract described above, and it was found that the antioxidant activity of the ginger extract has a great correlation with the ginger roll content.
실험예Experimental Example
5: 생강 추출물의 항염증 효과 5: Anti-inflammatory Effects of Ginger Extract
(1) 실험방법(1) Experimental method
1) 세포배양 및 세포 독성 측정1) Cell culture and cytotoxicity measurement
대식세포 계열(murine macrophage cell line)인 RAW 264.7 세포주를 한국 세포주 은행(KCLB, Seoul, Korea)으로부터 분양받았으며, 10% FBS(fetal bovine serum)와 1% 항생제(penicillin/streptomycin)를 첨가한 DMEM 배지를 이용하여 5% CO2가 존재하는 37℃ 인큐베이터에서 1주일에 2~3회 계대 배양하였다. RAW 264.7 cell line, a murine macrophage cell line, was distributed from Korea Cell Line Bank (KCLB, Seoul, Korea), and DMEM medium containing 10% FBS (fetal bovine serum) and 1% antibiotic (penicillin / streptomycin) 2 to 3 times and cultured for a week in the passage 37 ℃ incubator of 5% CO 2 is present using.
세포 독성을 MTT 법으로 측정하기 위하여, RAW 264.7 세포 1× 105 cells/well을 96 well plate에 분주하고, 37℃, 5% CO2 인큐베이터에서 24시간 동안 배양하였다. 배양한 세포를 세럼 프리(serum free) 배지로 교체한 후 LPS (100 ng/mL)와 시료(실시예 1, 실시예 2, 비교예)를 각각 처리하여 24시간 배양하여 5 mg/mL의 MTT 용액 10 μL를 각 well에 넣고 인큐베이터에서 4시간 동안 배양하였다. 배양 종료 후 상등액을 제거하고 각 well에 100 μL의 DMSO를 첨가하여 생성된 formazan 결정을 용해시켜 마이크로플레이트 판독기(microplate reader)로 550 nm에서 흡광도를 측정하였고, 세포독성은 시료의 흡광도를 대조군의 흡광도에 대한 백분율로 나타내었다.To measure cytotoxicity by MTT method, RAW 264.7
Rat 유래의 비만세포주(RBL-2H3)에 대한 세포독성능도 MTT 법으로 실험하였다. 본 실험에 사용한 세포주 RBL-2H3 cell은 한국 세포주 은행(Seoul, Korea)을 통해서 분양 받아 계대배양하면서 실험하였다. 세포배양에 사용된 배지는 10% FBS (fetal bovine serum)와 1% 항생제(penicillin/streptomycin)를 첨가한 MEM 배지를 이용하여 37℃에서 5% CO2 인큐베이터에서 2~3일간 배양한 후 사용하였다.
Cytotoxic activity against rat cell lines (RBL-2H3) was also tested by MTT method. The cell line RBL-2H3 cells used in this experiment were tested by subcultured through the pre-cultured through the Korea Cell Line Bank (Seoul, Korea). The medium used for cell culture was 5% CO 2 at 37 ° C. using MEM medium containing 10% FBS (fetal bovine serum) and 1% antibiotic (penicillin / streptomycin). It was used after incubating for 2-3 days in an incubator.
2) NO(Nitric Oxide) 생성량 측정2) NO (Nitric Oxide) production amount measurement
시료의 NO(Nitric Oxide) 생성 억제능을 측정하기 위하여, 각 시료(실시예 1, 실시예 2, 비교예)의 추출물 혹은 LPS를 처리한 상기 RAW 264.7 세포주 배양액을 nitrite 측정을 위해 100 μL를 96 well plate에 취하였다. 여기에 동량의 Griess 시약을 넣어 10분간 반응시킨 후 마이크로플레이트 판독기(microplate reader)를 이용하여 540 nm에서 흡광도를 측정하였다. Nitrite의 농도는 질산나트륨(NaNO2)을 사용하여 얻은 표준 직선과 비교하여 산출하였다.In order to measure the NO (Nitric Oxide) generation inhibitory ability of the sample, 100 μL of the wells or extracts of each sample (Example 1, Example 2, Comparative Example) or LPS-treated RAW 264.7 cell line for nitrite measurement 96 well Taken to plate. After adding the same amount of Griess reagent and reacting for 10 minutes, the absorbance was measured at 540 nm using a microplate reader. The concentration of nitrite was calculated by comparison with a standard straight line obtained using sodium nitrate (NaNO 2 ).
또한, 비만세포주 RBL-2H3을 1 ml(2 x 105 cells, 24 well plate)에 anti-DNP IgE(0.45 ㎍/ml)로 16시간 감작시키고, DNP-BSA(10 ㎍/mL)로 활성화시키기 전에 30분 동안 37℃에서 농도별 시료를 20 ml 처리하였다. 반응이 끝난 후 4℃에서 10분간 400 xg에서 원침하여 얻은 상등액 25 ㎕를 기질 p-nitrophenyl-N-acetyl-b-D-glucosaminide 25 ㎕와 37℃에서 1시간 반응시킨 후 stop solution(0.1 M NaCO/NaHCO, pH 10) 200 ㎕를 가하여 정지시키고 405 nm에서 흡광도를 측정하여 b-헥소사미니다제(b-hexosaminidase)의 양을 계산하였다.
In addition, the mast cell line RBL-2H3 was sensitized in 1 ml (2 x 10 5 cells, 24 well plates) with anti-DNP IgE (0.45 μg / ml) for 16 hours and activated with DNP-BSA (10 μg / mL). 20 ml of the concentration-specific sample was treated at 37 ° C. for 30 minutes before. After completion of the reaction, 25 μl of the supernatant obtained by centrifugation at 400 × g for 10 minutes at 4 ° C. was reacted with 25 μl of substrate p-nitrophenyl-N-acetyl-bD-glucosaminide at 37 ° C. for 1 hour, followed by a stop solution (0.1 M NaCO / NaHCO). , pH 10) 200 μl was added to stop and the absorbance was measured at 405 nm to calculate the amount of b-hexosaminidase.
(2) 실험 결과(2) experimental results
1) 초임계 추출물(생강유)의 세포독성 및 NO 생성 억제 활성 측정1) Determination of cytotoxicity and NO production inhibitory activity of supercritical extract (ginger oil)
생강의 초임계 추출물(생강유)의 항염증 효과를 측정하기 위해, 100 bar의 압력에서 35, 45, 55℃에서 추출된 생강유(실시예 1)의 NO 소거 활성을 측정하였다. 그 결과, 55℃의 100 ㎍/mL 농도에서 약간의 독성이 나타났으며, 추출온도가 높아지면 NO 생성 억제능이 낮아지는 경향을 나타내어 고온에서는 활성을 억제하는 성분도 유출되는 것으로 사료되나, 온도에 의한 유의적인 차는 없었다(도 4). 이와 같이, 35-55℃, 100 bar의 마일드한 조건에서 추출된 생강 초임계 오일에서도 높은 NO 소거능이 나타났다.
In order to measure the anti-inflammatory effect of ginger supercritical extract (ginger oil), NO scavenging activity of ginger oil (Example 1) extracted at 35, 45, 55 ° C. at a pressure of 100 bar was measured. As a result, a slight toxicity was observed at the concentration of 100 ㎍ / mL at 55 ° C, and the higher the extraction temperature, the lower the NO production inhibitory ability. There was no significant difference (FIG. 4). As such, high NO scavenging activity was also observed in ginger supercritical oil extracted under mild conditions of 35-55 ° C. and 100 bar.
2) 초임계 박의 세포독성 측정 및 NO 생성 억제 활성 측정2) Measurement of cytotoxicity and NO production inhibitory activity of supercritical gourd
실시예 2의 생강 추출물의 NO 생성에 대한 억제 효과를 실험하였다. 그 결과, 도 5에 나타낸 바와 같이 추출 온도에 비례하여 고농도에서 세포 독성이 나타났으며, NO 소거능도 온도 상승과 함께 증가하는 경향을 나타내어 실시예 1의 생강 추출물와 일치하는 좋은 상관관계를 나타냈다. 10-50 ㎍/mL의 농도 구간에서 농도 의존적으로 높은 억제율을 나타내므로, 실시예 1의 생강 추출물과 함께 실시예 2의 초임계 박도 항염증에 높은 효과가 있을 것으로 기대된다.
The inhibitory effect on the NO production of the ginger extract of Example 2 was tested. As a result, as shown in FIG. 5, cytotoxicity was observed at high concentrations in proportion to the extraction temperature, and the NO scavenging activity also showed a tendency to increase with a temperature increase, indicating a good correlation with the ginger extract of Example 1. Since the concentration-dependent high inhibition rate in the concentration range of 10-50 μg / mL, together with the ginger extract of Example 1 is expected to have a high effect on the supercritical thin anti-inflammatory.
3) 생강 추출물의 세포독성 및 NO 생성 억제능 측정3) Measurement of Cytotoxicity and NO Production Inhibition of Ginger Extract
비교예의 생강 추출물의 NO 생성에 대한 억제 효과를 실험하였다. 그 결과, 도 6에 나타낸 바와 같이 세포 독성은 나타나지 않았으며, NO 소거능은 농도 의존적으로 함께 증가하는 경향을 나타내었다(도 6).
The inhibitory effect on the NO production of the ginger extract of the comparative example was tested. As a result, as shown in FIG. 6, cytotoxicity was not shown, and NO scavenging ability was increased in a concentration-dependent manner (FIG. 6).
4) 진저롤(Gingerol)의 세포독성 측정 및 NO 생성 억제 활성 측정4) Cytotoxicity and NO production inhibitory activity of Gingerol
생강의 활성 성분으로 알려진 진저롤(gingerol)의 NO 생성에 대한 억제 효과를 테스트 한 결과, 100 ㎍/mL 까지는 세포 독성이 없었으며 10 ㎍/mL에서 50% 정도의 NO 억제능을 나타냈다(도 7).
As a result of testing the inhibitory effect on ginger's NO production, known as ginger's active ingredient, it showed no cytotoxicity up to 100 μg / mL and showed about 50% NO inhibition at 10 μg / mL (FIG. 7).
이상 살펴본 바와 같이 본 발명은 생강을 특정 조건으로 초임계 추출함으로써 생강 특유의 맛과 향기를 제거하거나 보완할 수 있을 뿐 아니라 짧은 시간 안에 추출 수율을 높으면서도 진저롤(gingerol)의 함량이 높은 추출물을 얻을 수 있어 식품산업에 매우 유용한 발명이다.As described above, the present invention not only removes or supplements ginger's unique taste and aroma by supercritical extraction under specific conditions, but also obtains an extract having a high content of gingerol (gingerol) while increasing the extraction yield in a short time. It is a very useful invention for the food industry.
또한, 본 발명은 상기 초임계 추출 후 남은 생강박을 활용하여 항염 활성이 높은 생강 추출물을 얻을 수 있다.
In addition, the present invention can obtain a ginger extract with high anti-inflammatory activity by utilizing the ginger foil remaining after the supercritical extraction.
이상에서 본 발명의 바람직한 실시예에 대하여 도시하고 또한 설명하였으나, 본 발명은 상기한 실시예에 한정되지 않고, 이하 청구범위에서 청구하는 본 발명의 요지를 벗어남이 없이 당해 발명의 분야에서 통상의 지식을 가진 자라면 누구든지 다양한 변형실시가 가능함은 물론이며, 그와 같은 변형은 청구범위의 기재 범위 내에 있게 된다.Although the preferred embodiments of the present invention have been illustrated and described above, the present invention is not limited to the above-described embodiments, and the general knowledge in the field of the present invention without departing from the gist of the present invention as claimed in the following claims. Anyone with a variety of modifications are possible, of course, such modifications are within the scope of the claims.
Claims (8)
(S2) 생강 분말을 초임계 이산화탄소를 이용하여 35 ~ 55℃의 온도, 100 ~ 400 bar의 압력에서 1 ~ 3 mL/min의 유속으로 1 ~ 3 시간 동안 초임계 추출법으로 추출하여 생강유를 얻는 단계;를 포함하는 생강 추출물 제조방법.
(S1) preparing a ginger powder; And
(S2) Ginger powder is extracted by supercritical extraction for 1 to 3 hours at a flow rate of 1 to 3 mL / min at a temperature of 35 to 55 ° C. and a pressure of 100 to 400 bar using supercritical carbon dioxide. Ginger extract manufacturing method comprising a.
(S1) 단계에서의 생강 분말은 평균 입도가 50 ~ 500 μm인 생강 추출물 제조방법.
The method of claim 1,
Ginger powder in the step (S1) is a ginger extract manufacturing method having an average particle size of 50 ~ 500 μm.
추출 수율이 2.5 ~ 3.0중량%인 생강 추출물 제조방법.
The method of claim 1,
Ginger extract manufacturing method with an extraction yield of 2.5 to 3.0% by weight.
(S3) 생강유를 얻은 후 남은 박을 생강 박 무게에 대하여 5 ~ 15배(w/v)의 60 ~ 90% 주정을 가하고 실온에서 6 ~ 36시간 동안 정치하는 단계; 및
(S4) 여과 및 농축하는 단계;를 더 포함하는 생강 추출물 제조방법.
The method of claim 1, wherein after step (S2)
(S3) adding remaining oil after ginger oil is added 5 to 15 times (w / v) of 60 to 90% spirits and weighed for 6 to 36 hours at room temperature; And
(S4) filtration and concentration; ginger extract manufacturing method further comprising.
Ginger extract prepared according to the method of any one of claims 1 to 4.
진저롤(gingerol)의 함량이 21 ~ 25중량%인 생강 추출물.
The method of claim 5,
Ginger extract of 21 to 25% by weight of gingerol.
10 ~ 100㎍/mL의 농도에서 NO(Nitric Oxide) 생성 억제 효과가 50 ~ 98%인 생강 추출물.
The method of claim 5,
Ginger extract with 50-98% NO (Nitric Oxide) production inhibitory effect at the concentration of 10 ~ 100㎍ / mL.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110008991A KR101324926B1 (en) | 2011-01-28 | 2011-01-28 | Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same |
PCT/KR2012/000437 WO2012102511A2 (en) | 2011-01-28 | 2012-01-18 | Ginger extract production method and ginger extract obtained thereby |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110008991A KR101324926B1 (en) | 2011-01-28 | 2011-01-28 | Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120087652A true KR20120087652A (en) | 2012-08-07 |
KR101324926B1 KR101324926B1 (en) | 2013-11-01 |
Family
ID=46581254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110008991A KR101324926B1 (en) | 2011-01-28 | 2011-01-28 | Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101324926B1 (en) |
WO (1) | WO2012102511A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102972755A (en) * | 2012-11-14 | 2013-03-20 | 汾州裕源土特产品有限公司 | Walnut oil soft capsule and preparing method thereof |
KR20180032302A (en) * | 2016-09-22 | 2018-03-30 | 주식회사 담터 | A method of extracting shogaol from ginger |
KR20210152236A (en) * | 2020-06-08 | 2021-12-15 | 광동제약 주식회사 | Steamed ginger extract with increased 6-gingerol contents and a method of preparation thereof |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111557432B (en) | 2013-02-08 | 2023-08-04 | 通用磨坊公司 | Low sodium food |
KR101582197B1 (en) * | 2013-12-11 | 2016-01-21 | 한국식품연구원 | Preparation method of ginger with increased shogaol content |
CN105495520A (en) * | 2015-11-26 | 2016-04-20 | 怀化学院 | Instant fresh-ginger powder and preparation method of the instant fresh-ginger powder |
CN107118842A (en) * | 2016-02-25 | 2017-09-01 | 山东省康福德实业有限公司 | A kind of oil of ginger extraction process flow of utilization supercritical extraction technique |
CN107460032A (en) * | 2017-09-18 | 2017-12-12 | 广西大学 | A kind of method for extracting effective components of ginger |
KR102063444B1 (en) | 2018-08-20 | 2020-01-08 | 이종관 | Manufacturing method of ginger powder with mild flavor |
CN113925948B (en) * | 2020-07-14 | 2023-10-10 | 香港大学 | Use of rhizoma Zingiberis recens total extract or its active component, pharmaceutical composition and preparation method |
KR20230044772A (en) | 2021-09-27 | 2023-04-04 | (주) 대진에프아이 | Complex processing method of ginger for producing oligosaccharide |
CN115721768A (en) * | 2022-12-01 | 2023-03-03 | 国纳之星(上海)纳米科技发展有限公司 | Preparation method of anti-inflammatory silk fibroin film, product and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100214801B1 (en) * | 1996-10-05 | 1999-08-02 | 신국현 | Antibiotics isolated from lindera obstiloba |
TWI290469B (en) * | 2000-07-12 | 2007-12-01 | Medical & Pharm Ind Tech & Dev | Method for manufacturing product with component capable of efficiently preventing inflammation and platelets agglutination form ginger and medical composition with the efficient component |
AU2002364380B2 (en) | 2001-11-26 | 2008-04-03 | Finzelberg Gmbh & Co. Kg | Ginger extract preparation |
KR100623003B1 (en) | 2004-12-22 | 2006-09-14 | 전북대학교산학협력단 | Manufacturing Method of Ginger Extract using Ultrasonication |
-
2011
- 2011-01-28 KR KR1020110008991A patent/KR101324926B1/en active IP Right Grant
-
2012
- 2012-01-18 WO PCT/KR2012/000437 patent/WO2012102511A2/en active Application Filing
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102972755A (en) * | 2012-11-14 | 2013-03-20 | 汾州裕源土特产品有限公司 | Walnut oil soft capsule and preparing method thereof |
KR20180032302A (en) * | 2016-09-22 | 2018-03-30 | 주식회사 담터 | A method of extracting shogaol from ginger |
KR20210152236A (en) * | 2020-06-08 | 2021-12-15 | 광동제약 주식회사 | Steamed ginger extract with increased 6-gingerol contents and a method of preparation thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2012102511A3 (en) | 2012-11-29 |
KR101324926B1 (en) | 2013-11-01 |
WO2012102511A2 (en) | 2012-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101324926B1 (en) | Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same | |
de Francisco et al. | Evaluation of radical scavenging activity, intestinal cell viability and antifungal activity of Brazilian propolis by-product | |
Tanvir et al. | Antioxidant properties of popular turmeric (Curcuma longa) varieties from Bangladesh | |
US10610562B2 (en) | Instant water soluble bioactive dietary phytonutrients composition of spice/herb extracts and a process for its preparation | |
Yumrutas et al. | Cell viability, anti-proliferation and antioxidant activities of Sideritis syriaca, Tanacetum argenteum sub sp. argenteum and Achillea aleppica subsp. zederbaueri on human breast cancer cell line (MCF-7) | |
CN103271393A (en) | Health care curcumin-sea-buckthorn beverage and preparation method thereof | |
Kuzmin et al. | Improvement technologies of aqueous-alcoholic infusions for the production of syrups | |
Köprü et al. | Optimization of processing parameters for the preparation of clove (Syzygium aromaticum) hydroalcoholic extract: A response surface methodology approach to characterize the biofunctional performance | |
Tisnadjaja et al. | Potency of cinnamomum burmannii as antioxidant and α glucosidase inhibitor and their relation to trans-cinamaldehyde and coumarin contents | |
KR102060702B1 (en) | Fermented drink using herb ingredients and manufacturing method thereof | |
KR101541520B1 (en) | A method for preparation of extract mixture having antioxidant and antiaging activity from dendropanax morbifera, cornus fruit and lycium chinense, and cosmetic composition containing the extract | |
Johari et al. | Evaluation of antioxidant activity of essential oils of some Indian medicinal plants by DPPH, FRAP and ABTS assay | |
KR102141609B1 (en) | Manufacturing method for onion juice | |
Vittaya et al. | Effect of solvent extraction on phytochemical component and antioxidant activity of vine and rhizome Ampelocissus martini | |
Bansode | Total flavonoid content of commonly consumed teas in India | |
KR102086854B1 (en) | Anti-oxidant or anti-inflammatory cosmetic compositions containing the plants extract of Cyperaceae | |
Okpoghono et al. | HPLC-DAD polyphenol profiling and antioxidant status from South-South region of Nigeria | |
KR101320149B1 (en) | Urushiol reduction disposed lacquer, lacquer extract by using the same and Method of manufacturing the same | |
Jha et al. | In vitro evaluation of free radical scavenging activity of Pistia stratiotes | |
Khan et al. | Antioxidant activities and inhibitory effects of dietary plants against sodium nitroprusside induced lipid peroxidation in the mouse brain and liver | |
Kim et al. | Assessment of antioxidant activity of garlic (Allium sativum L.) peels by various extraction solvents | |
Damayanti et al. | Antioxidant activity of doum fruit extract (hyphaene thebaica) as an alternative to antidiabetic drinks | |
Wabo et al. | In vitro antioxidant potential and phytochemical constituents of three cameroonian medicinal plants used to manage parasitic diseases | |
Adeogun et al. | Phenolic and antioxidant evaluation of the aqueous and ethanol extracts of unripe Citrus reticulata peels | |
Christabel et al. | In vitro antioxidant studies and the scavenging potential of pulp and peel of Prunus persica i. fruit on different solvent systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160927 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20171010 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20181023 Year of fee payment: 6 |